Vicarious Surgical (RBOTW) Long-Term Investments (2020 - 2021)
Vicarious Surgical (RBOTW) reported Long-Term Investments of $345.3 million for Q2 2021, little changed quarter-over-quarter from $345.3 million in Q1 2021.
Vicarious Surgical (RBOTW) Long-Term Investments (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOTW) has 2 years of Long-Term Investments data on file, last reported at $345.3 million in Q2 2021.
- Long-Term Investments for Q2 2021 came in at $345.3 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $345.3 million (changed N/A YoY), and the FY2020 annual result was $345.2 million, changed N/A from the prior year.
- Long-Term Investments held at $345.3 million in Q2 2021 per RBOTW's latest filing, from $345.3 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $345.3 million in Q2 2021 and troughed at $345.1 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 345.27 Mn |
| Mar 31, 2021 | 345.26 Mn |
| Dec 31, 2020 | 345.19 Mn |
| Sep 30, 2020 | 345.09 Mn |